wellbak-GM1-TAB
About wellbak-GM1-TAB
wellbak-GM1-TAB is a pharmaceutical product manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant company based in Patna, Bihar, India. It contains Glimepiride 1mg + Pioglitazone 15mg + Metformin 500mg, and forms part of our Physician range.
Therapeutic segment: Physician.
Product information
- Composition
- Glimepiride 1mg + Pioglitazone 15mg + Metformin 500mg
- Uses
- Type 2 Diabetes
- Recommended dosage
- 1 tablet daily before meal
Frequently asked questions
What is wellbak-GM1-TAB?
wellbak-GM1-TAB is a pharmaceutical product containing Glimepiride 1mg + Pioglitazone 15mg + Metformin 500mg, manufactured and marketed by A3A Pharmaceutical Pvt Ltd, Patna, Bihar, India.
What is wellbak-GM1-TAB used for?
As per the product information, wellbak-GM1-TAB is indicated for Type 2 Diabetes. Use only as directed by a qualified healthcare professional.
What is the composition of wellbak-GM1-TAB?
wellbak-GM1-TAB contains Glimepiride 1mg + Pioglitazone 15mg + Metformin 500mg.
What is the recommended dosage of wellbak-GM1-TAB?
1 tablet daily before meal Always follow the dosage prescribed by your doctor.
Which therapeutic segment does wellbak-GM1-TAB belong to?
wellbak-GM1-TAB is part of the Physician range of A3A Pharmaceutical Pvt Ltd.
Who manufactures wellbak-GM1-TAB?
wellbak-GM1-TAB is manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant pharmaceutical company based in Patna, Bihar, India. For distribution, PCD franchise or bulk supply enquiries call +91-83404-30743.
Enquiry
For distribution, PCD franchise or bulk supply enquiries about wellbak-GM1-TAB, contact A3A Pharmaceutical Pvt Ltd on +91-83404-30743 or email a3apharma@gmail.com.